Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Eleven-nineteen leukemia protein YEATS domain is a specialized protein module found in key transcriptional co-regulators (ENL, AF9, GAS41, YEATS2). It possesses an immunoglobulin-like β-sandwich fold with a ligand-binding pocket that selectively recognizes acylated lysines (e.g., acetylation, crotonylation) on histone tails, thereby acting as an epigenetic reader[1][5]. This recognition is crucial for recruiting chromatin-modifying complexes involved in gene activation or repression. YEATS domain-containing proteins regulate transcriptional elongation, chromatin remodeling, and are implicated in cancer pathogenesis, particularly leukemia, due to their fusion with MLL in oncogenic translocations[2][4][5]. Drug discovery efforts have begun to target this domain, exploiting its role in transcriptional control and tumorigenesis[4][5].
Inhibition of YEATS domain prevents recognition of acetylated and acylated lysine on histones, disrupting recruitment of transcriptional complexes and chromatin remodeling machinery, and potentially blocking oncogenic transcriptional programs
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eleven-nineteen leukemia protein YEATS domain (ENL YEATS domain).